Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes

Robb D. Kociol, Adrian F. Hernandez(Duke University), Gregg C. Fonarow(UCLA Medical Center), Eric Reyes(UCLA Health), Linda K. Shaw(UCLA Health), J.R. Horton(The University of Texas MD Anderson Cancer Center), Christopher M. O’Connor(Inova Health System), G. Michael Felker(Clinical Research Institute)

Circulation Heart Failure

July 9, 2011

10.1161/circheartfailure.111.962290

Cited by 243

Related Papers

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction

|Circulation|2010|4.8k

Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

|JAMA|2009|2.2k

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

|New England Journal of Medicine|2017|2.1k

Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)

|American Heart Journal|2005|2.1k

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

|Circulation|2006|2.1k